SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • The bitter truth

          In Bottle of Lies: Ranbaxy and The Dark Side of Indian Pharma, author Katherine Eban investigates the fall of Ranbaxy — a doom of its own making

          September 27, 2019
        • The Eclipse of A Star

          Investors worry about poor corporate governance practices at Sun Pharma and price erosion in the US generics market

          Prathamesh Mulye - March 25, 2019
        • "No matter how sincere your efforts though, the competition will never let go of things easily"

          Secret Diary of Ajay Piramal — Part 2

          N Mahalakshmi - May 04, 2018
        • Homesick

          Rising chronic illnesses and increasing health insurance coverage will spur domestic pharma industry growth

          January 02, 2018
        • Early Mover

          What makes Intas the most valuable privately-held pharma company in India

          Krishna Gopalan - June 09, 2017
        • Master Innovator

          Vishnukant Bhutada’s big bet on oncology has catapulted Shilpa Medicare into the global generics space

          Shilpa Elizabeth Abraham - June 09, 2017
        • Selling in tango

          Fortis Healthcare promoters are unlocking some value on their own

          Khushboo Balani - June 20, 2017
        • Niraj Dalal

          Sun Pharma has a robust pipeline in specialty business which will drive its profitability and free cash flow in the near future 

          January 13, 2017
        • Growth eclipse

          After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?

          Krishna Gopalan - January 22, 2016
        • If you've got it, <br> flaunt it </br>

          Pharma companies are giving OTC brands a makeover by splurging on advertising

          Himanshu Kakkar - September 29, 2015